179 related articles for article (PubMed ID: 26858454)
1. High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy.
Hathaway CK; Chang AS; Grant R; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2218-22. PubMed ID: 26858454
[TBL] [Abstract][Full Text] [Related]
2. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
Hathaway CK; Gasim AM; Grant R; Chang AS; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
Proc Natl Acad Sci U S A; 2015 May; 112(18):5815-20. PubMed ID: 25902541
[TBL] [Abstract][Full Text] [Related]
3. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456
[TBL] [Abstract][Full Text] [Related]
4. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy.
Shimazaki A; Kawamura Y; Kanazawa A; Sekine A; Saito S; Tsunoda T; Koya D; Babazono T; Tanaka Y; Matsuda M; Kawai K; Iiizumi T; Imanishi M; Shinosaki T; Yanagimoto T; Ikeda M; Omachi S; Kashiwagi A; Kaku K; Iwamoto Y; Kawamori R; Kikkawa R; Nakajima M; Nakamura Y; Maeda S
Diabetes; 2005 Apr; 54(4):1171-8. PubMed ID: 15793258
[TBL] [Abstract][Full Text] [Related]
6. Engulfment and cell motility protein 1 potentiates diabetic cardiomyopathy via Rac-dependent and Rac-independent ROS production.
Kakoki M; Bahnson EM; Hagaman JR; Siletzky RM; Grant R; Kayashima Y; Li F; Lee EY; Sun MT; Taylor JM; Rice JC; Almeida MF; Bahr BA; Jennette JC; Smithies O; Maeda-Smithies N
JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217360
[TBL] [Abstract][Full Text] [Related]
7. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
8. Assessment of diabetic nephropathy in the Akita mouse.
Chang JH; Gurley SB
Methods Mol Biol; 2012; 933():17-29. PubMed ID: 22893398
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.
Pezzolesi MG; Katavetin P; Kure M; Poznik GD; Skupien J; Mychaleckyj JC; Rich SS; Warram JH; Krolewski AS
Diabetes; 2009 Nov; 58(11):2698-702. PubMed ID: 19651817
[TBL] [Abstract][Full Text] [Related]
10. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.
Yu L; Su Y; Paueksakon P; Cheng H; Chen X; Wang H; Harris RC; Zent R; Pozzi A
Kidney Int; 2012 Jun; 81(11):1086-97. PubMed ID: 22297672
[TBL] [Abstract][Full Text] [Related]
11. ELMO1 protects renal structure and ultrafiltration in kidney development and under diabetic conditions.
Sharma KR; Heckler K; Stoll SJ; Hillebrands JL; Kynast K; Herpel E; Porubsky S; Elger M; Hadaschik B; Bieback K; Hammes HP; Nawroth PP; Kroll J
Sci Rep; 2016 Nov; 6():37172. PubMed ID: 27849017
[TBL] [Abstract][Full Text] [Related]
12. Arginase-2 mediates diabetic renal injury.
Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
14. Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia.
Iyengar SK; Freedman BI; Sedor JR
Semin Nephrol; 2007 Mar; 27(2):208-22. PubMed ID: 17418689
[TBL] [Abstract][Full Text] [Related]
15. Association of ELMO1 gene polymorphism and diabetic nephropathy among Egyptian patients with type 2 diabetes mellitus.
Bayoumy NMK; El-Shabrawi MM; Leheta OF; Abo El-Ela AEM; Omar HH
Diabetes Metab Res Rev; 2020 Jul; 36(5):e3299. PubMed ID: 32043290
[TBL] [Abstract][Full Text] [Related]
16. Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population.
Wu HY; Wang Y; Chen M; Zhang X; Wang D; Pan Y; Li L; Liu D; Dai XM
J Endocrinol Invest; 2013 May; 36(5):298-302. PubMed ID: 22842811
[TBL] [Abstract][Full Text] [Related]
17. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
18. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse.
Fang F; Bae EH; Hu A; Liu GC; Zhou X; Williams V; Maksimowski N; Lu C; Konvalinka A; John R; Scholey JW
Diabetologia; 2015 Jul; 58(7):1668-78. PubMed ID: 25957229
[TBL] [Abstract][Full Text] [Related]
20. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
